STOCK TITAN

BioLife Solutions to Report Third Quarter 2024 Financial Results and Business Update on November 12, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

BioLife Solutions (NASDAQ: BLFS), a leading developer and supplier of bioproduction products for cell and gene therapies and biopharma markets, has scheduled its third quarter 2024 financial results release for November 12, 2024, after market close. The company will host a conference call and webcast at 4:30pm ET to discuss financial results and provide a business update. Investors can access the webcast through BioLife's website, or join via phone using toll-free numbers. A replay will be available for 90 days on the company's investor relations page.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+2.86% News Effect

On the day this news was published, BLFS gained 2.86%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

BOTHELL, Wash., Oct. 31, 2024 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's third quarter 2024 financial results will be released after market close on Tuesday, November 12, 2024. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general business update.

To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at https://www.biolifesolutions.com/earnings. In addition, the conference call will be accessible by dialing toll-free 1-833-630-0431 or 1-412-317-1808 for international callers. A webcast replay will be available approximately two hours after the call and will be archived on https://investors.biolifesolutions.com for 90 days.

About BioLife Solutions
BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X.

Media & Investor Relations

At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com 

Investors
LHA Investor Relations
Jody Cain
(310) 691-7100
jcain@lhai.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-report-third-quarter-2024-financial-results-and-business-update-on-november-12-2024-302293378.html

SOURCE BioLife Solutions, Inc.

FAQ

When will BioLife Solutions (BLFS) release Q3 2024 earnings?

BioLife Solutions will release its Q3 2024 earnings after market close on Tuesday, November 12, 2024.

What time is BioLife Solutions (BLFS) Q3 2024 earnings call?

BioLife Solutions' Q3 2024 earnings call is scheduled for 4:30pm ET (1:30pm PT) on November 12, 2024.

How can I access BioLife Solutions (BLFS) Q3 2024 earnings call?

You can access the call via webcast on BioLife's investor relations website or by phone at 1-833-630-0431 (US toll-free) or 1-412-317-1808 (international).
Biolife Solutions Inc

NASDAQ:BLFS

BLFS Rankings

BLFS Latest News

BLFS Latest SEC Filings

BLFS Stock Data

1.17B
47.18M
2.11%
104.51%
8.23%
Medical Instruments & Supplies
Electromedical & Electrotherapeutic Apparatus
Link
United States
BOTHELL